Angiosarcoma of the scalp in an elderly man with HIV infection: A case report
Keywords:
Angiosarcoma, HIV infectionAbstract
PHUAMORNGUL P, KATTIPATHANAPONG P. ANGIOSARCOMA OF THE SCALP IN AN ELDERLY MAN WITH HIV INFECTION: A CASE REPORT. THAI J DERMATOL 2020; 36: 90-96.
INSTITUTE OF DERMATOLOGY, DEPARTMENT OF MEDICAL SERVICES, MINISTRY OF PUBLIC HEALTH, BANGKOK, THAILAND.
Cutaneous angiosarcoma is a rare malignant tumor of vascular mesenchymal origin with a propensity for local recurrence and metastasis associated with a poor prognosis unless diagnosed early. The most common type is angiosarcoma of the face and scalp, especially in elderly men. We reported a case of HIV infected elderly man with angiosarcoma of the scalp which treated by local wide excision followed by radiotherapy. To our knowledge, few studies have been reported about angiosarcoma in HIV infection which the pathogenesis is still controversial in the immunocompromised host.
References
Conic RRZ, Damiani G, Frigerio A, et al. Incidence and outcomes of cutaneous angiosarcoma: A SEER population-based study [published online ahead of print, 2019 Jul 13]. J Am Acad Dermatol 2019;S0190-9622(19)32382-5.
Lahat G, Dhuka AR, Hallevi H, et al. Angiosarcoma: clinical and molecular insights. Ann Surg 2010;251:1098–106.
Govender PS. Atypical presentation of angiosarcoma of the scalp in the setting of Human Immunodeficiency Virus (HIV). World J Surg Oncol 2009;7:99.
Razek AA, Huang BY. Soft tissue tumors of the head and neck: imaging-based review of the WHO classification. Radiographics 2011;31:1923–54.
Tateishi U, Hasegawa T, Kusumoto M, et al. Metastatic angiosarcoma of the lung: spectrum of CT findings. AJR Am J Roentgenol 2003;180:1671-4.
Alqumber NA, Choi JW, Kang MK. The management and prognosis of facial and scalp angiosarcoma: a retrospective analysis of 15 patients. Ann Plast Surg 2019;83:55-62.
Mitsuyasu RT. Non-AIDS-Defining Cancers. Top Antivir Med 2014;22:660–5.
Pantanowitz L, Schlecht HP, Dezube BJ. The growing problems of non-AIDS-defining malignancies in HIV. Curr Opin Oncol 2006;18:469-78.
Burgi A, Brodine S, Wegner S, et al. Incidence and risk factors for the occurrence of non-AIDS-defining cancers among human immunodeficiency virus-infected individuals. Cancer 2005;104:1505-11.
Clifford GM, Polesel J, Rickenbach M, et al. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. J Natl Cancer Inst 2005;97:425-32.
Penel N, Marréaud S, Robin YM, Hohenberger P. Angiosarcoma: state of the art and perspectives. Crit Rev Oncol Hematol 2011;80:257-63.
Lee KC, Chuang SK, Philipone EM, Peters SM. Characteristics and Prognosis of Primary Head and Neck Angiosarcomas: A Surveillance, Epidemiology, and End Results Program (SEER) Analysis of 1250 Cases. Head and Neck Pathology 2019;13:378–85.
Pawlik TM, Paulino AF, McGinn CJ, et al. Cutaneous angiosarcoma of the scalp: a multidisciplinary approach. Cancer 2003;98:1716-26.
Ishida Y, Otsuka A, Kabashima K. Cutaneous angiosarcoma: update on biology and latest treatment. Curr Opin Oncol 2018;30:107-12.
Torres HA, Mulanovich V. Management of HIV infection in patients with cancer receiving chemotherapy. Clin Infect Dis 2014;59:106-14.
Wei MT, Shankar GM, Ely SE, Bartolotta RJ, Sappino AP, Posnett DN. Spontaneous regression of angiosarcoma. Cancer Arch 2019;1:1-5.
Downloads
Published
How to Cite
Issue
Section
License
เนื้อหาและข้อมูลในบทความที่ลงตีพิมพ์ในวารสารโรคผิวหนัง ถือเป็นข้อคิดเห็นและความรับผิดชอบของผู้เขียนบทความโดยตรงซึ่งกองบรรณาธิการวารสาร ไม่จำเป็นต้องเห็นด้วย หรือร่วมรับผิดชอบใดๆ
บทความ ข้อมูล เนื้อหา รูปภาพ ฯลฯ ที่ได้รับการตีพิมพ์ในวารสารโรคผิวหนัง ถือเป็นลิขสิทธิ์ของวารสารฯ หากบุคคลหรือหน่วยงานใดต้องการนำทั้งหมดหรือส่วนหนึ่งส่วนใดไปเผยแพร่ต่อหรือเพื่อกระทำการใดๆ จะต้องได้รับอนุญาตเป็นลายลักอักษรจากบรรณาธิการวารสารโรคผิวหนังก่อนเท่านั้น
